Long non‑coding RNA HOTTIP is able to predict poor prognosis in various neoplasms: A meta‑analysis
- Authors:
- Published online on: June 15, 2017 https://doi.org/10.3892/mco.2017.1293
- Pages: 263-266
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Abstract
HOXA distal transcript antisense RNA (HOTTIP), a critical oncogenic long non‑coding RNA, has been reported to be aberrantly regulated in various cancer types. The present meta‑analysis aimed to investigate HOTTIP as a potential clinical applicable prognostic biomarker in malignant neoplasms. Literature collections were performed by searching the electronic databases, PubMed and Web of Science (up to July 20, 2016). All the relevant searches were conducted to identify the association of HOTTIP with the overall survival (OS) rate. A total of six articles consisting of 508 patients were included in the present meta‑analysis. The results suggested that the overexpression of HOTTIP is closely correlated with poor OS (hazard ratio=2.28; 95% confidence interval=1.71‑3.04; P=0.000). In conclusion, the present meta‑analysis has demonstrated that an increased expression level of HOTTIP is correlated with poor OS in different types of cancer, suggesting that HOTTIP potentially serves as a reliable prognostic biomarker in different types of cancer.
